Sanofi

SNY | NASDAQ

Price Alert Chart Builder DCF Calculator

$44.34

+$1.21 (+2.81%)

At close: Oct 30, 2026, 4:00 PM ET

$44.39

+$0.05 (+0.11%)

Pre-market: Nov 2, 2026, 7:04 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023	Q3 2023 Sep 30, 2023	Q2 2023 Jun 30, 2023	Q1 2023 Mar 31, 2023	Q4 2022 Dec 31, 2022	Q3 2022 Sep 30, 2022	Q2 2022 Jun 30, 2022	Q1 2022 Mar 31, 2022	Q4 2021 Dec 31, 2021	Q3 2021 Sep 30, 2021	Q2 2021 Jun 30, 2021	Q1 2021 Mar 31, 2021
Revenue	12.3B	11.24B	12.21B	13.17B	10.74B	10.61B	7.63B	14.16B	11.38B	9.73B	12.2B	12.7B	10.68B	10.86B	11.46B	13.14B	10.74B	10.05B	10.42B	10.83B	9.05B	8.89B
Cost of Revenue	3.02B	3.14B	3.63B	3.41B	2.99B	2.89B	2.27B	4.09B	3.41B	2.97B	4.05B	3.84B	3.27B	3.08B	3.73B	3.83B	3.25B	2.88B	3.48B	3.24B	2.86B	2.68B
Gross Profit	9.28B	8.11B	8.58B	9.76B	7.74B	7.72B	5.36B	10.07B	7.97B	6.76B	8.15B	8.86B	7.41B	7.78B	7.72B	9.31B	7.49B	7.17B	6.94B	7.59B	6.19B	6.2B
Operating Income	2.38B	2.27B	-1.04B	3.62B	1.47B	2.23B	573M	3.64B	1.6B	1.24B	342M	3.21B	1.86B	2.46B	4.1B	2.72B	1.43B	2.4B	1.47B	3.03B	1.56B	2.06B
Interest Income	77M	60M	23.69M	114M	154.76M	86M	185.03M	133M	258.84M	147M	280.12M	143M	258.59M	161M	141.24M	52M	24.01M	10M	1.02M	2M	2.03M	14M
Pretax Income	828M	2.01B	-1.16B	3.51B	1.47B	2.2B	451M	3.58B	1.42B	1.09B	-249M	3.1B	1.72B	2.47B	4.08B	2.68B	1.38B	2.35B	1.41B	2.94B	1.5B	1.98B
Net Income	343M	1.61B	-801M	2.8B	3.94B	1.87B	499M	2.82B	1.11B	1.13B	-555M	2.53B	1.44B	2B	3.11B	2.08B	1.18B	2.01B	1.13B	2.31B	1.21B	1.57B
Selling & General & Admin	2.63B	2.49B	2.4B	2.29B	2.63B	2.39B	1.24B	2.68B	2.66B	2.11B	2.93B	2.58B	2.58B	2.61B	2.9B	2.64B	2.57B	2.38B	2.76B	2.27B	2.34B	2.19B
Research & Development	2.23B	1.75B	2.29B	1.83B	1.91B	1.81B	2.12B	1.85B	1.7B	1.67B	1.87B	1.66B	1.63B	1.56B	1.82B	1.74B	1.66B	1.49B	1.59B	1.44B	1.4B	1.27B
Other Expenses	2.03B	1.6B	4.92B	2.01B	1.73B	1.29B	1.43B	1.9B	2.02B	1.74B	3.01B	1.4B	1.35B	1.15B	-1.1B	2.2B	1.83B	908M	1.12B	848M	900M	684M
Operating Expenses	6.9B	5.84B	9.61B	6.14B	6.27B	5.48B	4.79B	6.44B	6.38B	5.52B	7.81B	5.65B	5.56B	5.32B	3.62B	6.58B	6.06B	4.78B	5.47B	4.56B	4.63B	4.14B
Interest Expense	287M	178M	-100.59M	227M	201.37M	213M	302.11M	265M	304.16M	247M	293.88M	318M	225.9M	168M	205.26M	103M	183.73M	88M	178.11M	87M	190.93M	99M
Selling & Marketing Expenses	169M	167M	n/a	n/a	n/a	169M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.92B	8.98B	13.24B	9.55B	9.26B	8.37B	7.06B	10.52B	9.79B	8.49B	11.86B	9.49B	8.82B	8.4B	7.35B	10.41B	9.31B	7.66B	8.94B	7.8B	7.49B	6.83B
Income Tax Expense	451M	420M	-348M	680M	230M	481M	4M	737M	299M	104M	309M	563M	271M	459M	910M	601M	163M	332M	267M	606M	278M	404M
Shares Outstanding (Basic)	2.39B	2.41B	2.44B	2.44B	2.47B	2.47B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B
Shares Outstanding (Diluted)	2.39B	2.41B	2.44B	2.47B	2.47B	2.47B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B
EPS (Basic)	0.14	0.67	-1.48	1.15	1.60	0.76	0.35	1.13	0.45	0.46	-0.22	1	0.57	0.80	1.24	0.83	0.47	0.81	0.45	0.93	0.48	0.63
EPS (Diluted)	0.14	0.67	-1.46	1.14	1.60	0.76	0.35	1.13	0.45	0.46	-0.22	1	0.57	0.80	1.24	0.83	0.47	0.81	0.45	0.93	0.49	0.63
EBITDA	1.68B	2.72B	3.82B	4.2B	1.89B	2.77B	563M	4.25B	2.03B	1.87B	425M	3.92B	2.48B	3.11B	4.94B	3.46B	1.92B	2.86B	1.94B	3.42B	1.98B	2.46B
EBIT	1.12B	2.18B	1.85B	3.74B	1.51B	2.37B	354M	3.77B	1.53B	1.38B	-150M	3.35B	1.93B	2.62B	4.26B	2.78B	1.46B	2.41B	1.52B	3.03B	1.59B	2.07B
Depreciation & Amortization	552M	535M	1.97B	461M	378M	399M	209M	479M	499M	484M	575M	562M	546M	489M	683M	686M	461M	449M	420M	385M	386M	389M